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Abstract 
We have revealed a remarkable degree of intra-population variability among several 
individual venom samples from the European adder (Vipera berus berus) within a defined 
population in eastern Hungary. There was significant variation in venom protein profiles, both 
gender-specific and age-related, using one-dimensional electrophoresis and gelatin-
zymography. There was obvious interspecimen variability in phospholipase A2 activity, 
phospholipase A2-spectra (using MALDI-TOF MS based on molecular weights of 
components), and toxicity assays (LD50). Venom samples had variable neuromuscular 
paralysing effects on chick biventer cervicis nerve-muscle preparations. The relevance of 
variable venom yields is discussed. The data suggest that individual venom variation among 
V. b. berus living in eastern Hungary might contribute to the wide range of clinical 
manifestations in envenomed patients, notably neurotoxicity, that is not typical of V. b. berus 
envenoming elsewhere in Europe. 
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1. Introduction 
The common adder (V. berus), which is the most widely distributed Vipera species 
causes many cases of snake-bite envenoming throughout Northern and Central Europe.  It is 
represented by the nominate subspecies (V. b. berus) in most parts of the continent 
(Ursenbacher et al., 2006). Vipera berus is the only indigenous viper in United Kingdom, 
Sacndnavian countries, Netherlands, Belgium, Luxembourg and Poland. In Hungary, V. b. 
berus is the sole clinically significant native venomous snake, mainly occurring in three 
separated regions: the Zemplén Hills and Eperjes-Tokaj Range in the Northeast, the Upper 
Tisza Valley in the East, and Somogy and Zala counties in the Southwest. 
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Intraspecies variation in venom composition is of scientific interest for reasons of 
ecology, taxonomy/evolution, clinical manifestations of envenoming and epidemiology of 
snake-bites, and design and production of antivenom (Casewell et al., 2014). Regional 
differences in venom composition have been shown within some populations of the long-
nosed viper (V. ammodytes) (Balija et al., 2005) and asp viper (V. aspis) (Ferquel et al., 2007). 
Individual variability in venom composition within dicrete snake populations (intrapopulation 
differences) are known for /DWDVWH¶VYLSHUV. latastei (Arez et al., 1994)) and V. ammodytes 
(Master and Kornalík, 1965). Significant individual differences have been detected in the 
phospholipase A2 (PLA2) content of venom within a south-eastern French V. aspis population 
(Ferquel et al., 2007). More recently, age-dependent venom variation was described in V. 
ammodytes and the Caucasus viper (V. kaznakovi) in Turkey (Arikan et al., 2014).  
Although the venom of V. berus has been extensively studied in the past 20 years, the 
main venom characteristics in different localities and populations remain unknown. Most 
studies involved V. b. berus from Russian and France (Guillemin et al., 2003; Malenev et al., 
2007; Ramazanova et al., 2008; /DWLQRYLüet al., 2016), while one used V. berus venom from 
former Czechoslovakia (Mebs and Langelüddeke, 1992). These V. b. berus venoms contained 
oedema-forming, anti-haemostatic, anticoagulant, fibrinolytic, proteolytic, haemorrhagic and 
myotoxic components (Saint Girons and Detrait, 1978; Mebs and Langelüddeke, 1992; 
Calderón et al., 1993; Samel et al., 2003; LatinoviüHWDO). There have been few studies 
of variations in V. berus venom composition. However, Nedospasov and Rodina (1992) 
described age-related variations in amidolytic activity of V. b. berus venoms, Malenev et al. 
(2007) showed variations in venom LD50 between V. b. berus populations in different Russian 
localities, and Zaitseva (2011) investigated regional variations in Russian V. berus venom 
composition in the Volga basin. 
The aim of the present study was to investigate variation in venom yield and 
composition among samples from individual specimens from the same V. b. berus population 
in eastern Hungary, in the hope of better understanding unusual clinical manifestations in 
envenomed patients.  
 
2. Materials and methods 
2.1. Collection and storage of venom 
Venoms from healthy V. b. berus specimens of both sexes were milked in the field, 
very soon after capture in eastern Hungary between 2008 and 2011. All venoms were 
collected during mid-spring in order to avoid possible seasonal changes in venom 
composition. Individual, not pooled, venom samples were used to investigate the individual 
venom variability (Chippaux et al., 1991). Glass capillaries, Pasteur pipettes or manual gland 
massage were used for milking, depending on the size of specimens, following induced strike 
on Eppendorf tubes. Total lengths were recorded and the snakes were then released. Venoms 
samples were flash frozen in liquid nitrogen in the field. Each venom was lyophilized in the 
laboratory, its dry weight was measured and it was then stored in dark at -80°C until used. 
Two venoms were used as control: one was collected from an adult V. b. berus specimen (of 
unknown gender) in the Ybbs Mountain of eastern Austria in May 2006; the other was from 
an adult Nikolsky's adder (V. nikolskii) (gender unknown) from Pidlisne, central Ukraine, 
collected in early May 2009. Statistical significance was determined using z-test with two-
tailed distribution and two-sample equal variance at 95% confidence interval. 
 
2.2. Limitations 
Vipera berus is a relatively small species with a lower venom yield compared to other 
European viperids (i.e. V. ammodytes, V. latastei).  
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2.3. Protein content determination and one-dimensional Sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE)  
Protein concentration was determined by the method of Bradford (1976) using bovine 
serum albumin (BSA) as the standard. Absorbance was measured at 595 nm. In order to 
estimate the molecular mass of the proteins, the individual crude venoms were initially 
separated by SDS-PAGE, in a discontinuous gel and buffer. The resultant pellets were 
dissolved in the sample buffer and the electrophoresis was performed on 10 to 18% linear 
sodium dodecyl sulfate (SDS)-polyacrylamide gradient gels as described previously 
(Laemmli, 1970). Marker proteins (used for quantification of molecular weight of the venom) 
were included in the runs and the gels were stained with coomassie blue and subsequently 
analysed using UVIDoc software (UVI, Cambridge, UK). For statistical analysis of SDS-
PAGE the band obtained for the individual samples have been grouped into eight groups, as 
follows: juvenile female (n=2), juvenile male (n=3), subadult female (n=4), subadult male 
(n=5), adult female (n=8), adult male (n=3), plus the control samples of V. b. berus from 
Austria (n=1) and V. nikolskii (n=1). Bands presence (1) and absence (0) were scored. 
Hierarchical clustering, Unweighted Pair-Group Method on group average (UPGMA) using 
Jaccard`s similarity coefficient, was run using the SYN-TAX 2000 program package (Podani, 
2001). In order to determine the congruence between the dendrogram and the underlying 
resemblance matrix, the cophenetic correlation coefficient (rcs) was also calculated. 
 
2.4. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-
TOF MS)  
MALDI-TOF MS is a suitable analytical tool in the detection and direct measurement 
of molecular weights of components in crude snake venoms (Favreau et al., 2006). MALDI-
TOF MS measurements of the individual crude venoms were carried out in linear mode using 
a Bruker Biflex III mass spectrometer (Bruker Daltonik GmbH, Bremen, Germany). External 
calibration was applied using the >M+H@+ m/z: 12361.1971 and >M+2H@2+ m/z: 6181.1023 
peaks of Cytochrome c as calibrants. Sinapinic acid (3,5-dimethoxy-4-hydroxacinnamic acid) 
was the matrix solution at final concentration of 20 mg/ml using 0.1 % trifluoroacetic acid 
7)$VROXWLRQLQZDWHUDFHWRQLWULOHDVVROYHQW7KHYHQRPZDVGLVVROYHGLQȝORI
7)$DQGDȝOVDPSOHSOXVȝORIPDWUL[VROXWLRQZHUHPL[HGDQGȝOZDVDSSOLHGWR
the target plate and allowed to dry at room temperature. Spectra from multiple (at least 100) 
laser shots (N2 laser, 337 nm) were averaged prior to analysis. Samples analysed four times to 
check the accuracy and reproducibility of the results; the average variance is maximally 5 Da 
in each molecular mass range. Statistical significance was determined using z-test with two-
tailed distribution and two-sample equal variance at 95% confidence interval. 
 
2.5. Phospholipase A2 activity assay 
Phospholipase A2 (PLA2) activity of the venoms was determined by the method of 
Santoro et al. (1999). Briefly, venoms were diluted in 1 mL cold (4°C) PBS pH 7.4, and 1 µg 
protein was added to 1.5 mL of reaction solution (100 mM NaCl, 10 mM CaCl2, 7 mM Triton 
X-100, 0.265% soybean lecithin, 98.8 mM phenol red, pH7.6) in a spectrophotometer cuvette. 
The solution was immediately homogenized and read at 558 nm (at room temperature). The 
definition of 1 U of PLA2 activity was taken as the amount of venom (mg of protein/assay) 
producing a decrease of 0.001 absorbance units per minute under the conditions described. 
PLA2 activity was expressed as U/mg of two independent experiments. Statistical analysis on 
PLA2 activity was performed on MATLAB Version 8.4.0.150421(R2014b) using Two-way 
$129$WRWHVWIRUGLIIHUHQFHVLQWKHPHDQRIVDPSOHSRSXODWLRQVEHORQJLQJWRJURXSVµVH[¶
ZLWK FDWHJRULHV µPDOH¶ DQG µIHPDOH¶ DQG DJH ZLWK FDWHJRULHV µMXYHQLOH¶ µVXEDGXOW¶ DQG
µDGXOW¶ 
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2.6. Protease activity/substrate zymography 
Gelatin-zymography can be applied to evaluate protease activities of venoms (Hasson 
et al., 2004; Malta et al., 2008). For the determination of proteolytic activity of venoms, 
samples were homogenized with 100 mM Tris±HCl buffer pH 8.0 (Sigma-Aldrich) containing 
150 mM NaCl (Reanal, Budapest, Hungary) to final concentrations of 5 mg/ml (Hasson et al., 
2004). The homogenates were sonicated and shaken to disintegrate remaining organelles as 
described by Schlereth et al. (2000). After centrifugation (13.000×g, 2x5 min, Biofuge), the 
supernatants were used as crude protein extracts. Protease activity analysis of samples (10-20 
µl of 22 µg protein) was carried out using gelatin-containing SDS slab gels according to 
Hasson et al. (2004) and Malta et al. (2008). Samples were mixed with equal volumes of 
SURWHLQ ORDGLQJ EXIIHU ODFNLQJ ȕ-mercaptoethanol and loaded on 10% SDS-polyacrylamide 
gels containing 0.04% gelatin. The gels were run at 20 mA/gel at 4 oC in the dark. To renature 
venom proteolytic enzymes, SDS was removed from gels by three 10 min washes in 2.5% 
(v/v) Triton X-100 in reactivating buffer. The gels were then incubated overnight at 37 oC in 
reactivating buffer (50 mM Tris-HCl pH 8.0, 5mM CaCl2, 10 ng NaN3) in dark (Hasson et al., 
2004). Local gelatin degradations were visible after Coomassie Blue staining (Coomassie 
Brilliant Blue R250) and revealed the sites of proteases with gelatinolytic activities. 
 
2.7. Determination of venom toxicity (LD50)  
Toxicity was assessed as described previously by Theakston and Reid (1983) on 
Swiss-Webster male mice (n=6/group). Four individual venoms were randomly chosen from 
the Hungarian adder population and tested together with the control samples (n=2). The dose 
range of venoms was the following: 1.0; 0.8; 0.7; 0.6; 0.5; 0.4; 0.3; and 0.25 µg/g i.v. Control 
mice (n=6) were injected with normal (venom free) saline solution. LD50 calculation was 
performed by probit analysis using Minitab 16 software. Distribution fitting was tested using 
3HUVRQ¶V JRRGQHVV-of-fit test. Additionally, pairwise relative potency tests have been 
performed to compare the LD50 fiducial estimated toxicity between each pair of samples. 
Experiments were authorised by the Committee of Animal Research of the University of 
Debrecen. 
 
2.8. Neuromuscular studies on chick biventer cervicis  
The chick biventer cervicis (CBC) preparation is sensitive to snake toxins and allows 
prejunctional effects to be distinguished from postjunctional ones (Harvey et al., 1994). The 
CBCs were removed from chicks which had been killed by exposure to CO2, and the 
preparations were set up as described previously by Harvey et al. (1994). Preparations were 
mounted under 1 g resting tension in 10 ml  glass organ baths containing Krebs-Henseleit 
solution with the following composition (mM): NaCl, 118.4; KCl, 4.7; MgSO4, 1.2; KH2PO4, 
1.2; CaCl2, 2.5; NaHCO3, 25; and glucose, 11.1. The solution was maintained at 37°C and 
continuously bubbled with 95% O2/ 5% CO2. Preparations were stimulated through the motor 
nerve via silver ring electrodes (0.2 msec pulses, voltage greater than required for maximal 
twitches at 0.1 Hz), and responses were also obtained to sub-maximal concentrations of ACh 
P0FDUEDFKROȝ0DQG.&OP0EHIore and after exposure to venom 
 
3. Results 
3.1 Snakes and the amount of milked venom 
The studied lowland V. b. berus population lives in a limited area (mixed forest; 
Quercus robur - Fraxinus angustifolia subsp. pannonica - Carpinus betulus) in the Upper 
Tisza Valley up to an elevation of 100-150 m above the sea level. Specimens were collected 
on the edges of forest, woodland cuts, and edges of marshes. Overall 25 specimens were 
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milked from the Hungarian adders: 11 males and 14 females, their total length was ranged 
from 16.2 to 77.4 cm (Table 1). The average total length was 50.7 cm (Males: 16.2-60.2 cm, 
average: 43.5 cm. Females: 26.3-77.4 cm, average: 56.5 cm). According to their total length, 
adders were classified into three main approximate age-groups: i) juveniles (n=5; 16.2-36.7 
cm), ii) subadults (n=9; 42.5-50.7 cm), iii) and adults (n=11; 58.3-77.4 cm).  
Dry weight of the milked venoms varied between 0.8 and 15.7 mg (average was 5.7 
mg/specimen), while it was 2.0 mg in V. nikolskii and 6.3 mg in the Austrian V. b. berus. Of 
the Hungarian adders, the average dry weight of venom was 4.7 mg in males and 6.6 mg in 
case of females. The difference was statistically insignificant between the genders (P-
value=0.3399, at 95% confidence interval, 2-tailed). The average dry weight of venoms was 
the following in the given age-groups: i) juveniles: 1.9 mg, ii) subadults 4.1 mg, and iii) 
adults: 8.9 mg. The difference was statistically significant between the juveniles and adults 
(P-value= 0.0057, at 95% confidence interval, 2-tailed), and between the subadults and adults 
(P-value=0.0227, at 95% confidence interval, 2-tailed). No significant difference was detected 
in the dry weight of venoms between the juvenile and subadult specimens (P-value=0.4021, at 
95% confidence interval, 2-tailed).  
 
3.2. Comparison of the electrophoretic protein pattern of venom samples 
As determined by one-dimensional SDS-PAGE electrophoresis (non-reduced) (Fig. 
1A), there is a clear variation in the number, the location, the abundance, and the intensity of 
protein bands among the individual venoms. The number of bands varies between 7 and 18 
(average: 12.8) in the samples. Control samples presented 11 and 12 bands, respectively that 
showed the following molecular weights: 79, 62, 57, 45, 44, 42, 25.5, 18, 17, 16, 14 kDa 
(Austrian V. b. berus) and 79, 62, 58, 45, 42, 40, 25, 19, 18, 17, 16, 13.5 kDa (V. nikolskii). 
The protein profile of V. nikolskii and the Austrian V. b. berus was different from the venom 
pattern of the Hungarian adders only in two protein bands (located in 57 and 41.5 kDa 
ranges). The abundance and intensity of bands in the molecular mass range between 13 and 
15 kDa on the SDS-PAGE correspond to the expected PLA2s with a great predominance of 
proteins of molecular masses, indicated by their intensity and relative quantity. (Fig. 1A). 
These proteins were the dominant components of the Hungarian adder venoms and of the two 
controls, as well.  
Major differences are notable in protein bands of individual venoms in the molecular 
mass range of 20-24 kDa, 30-40 kDa and 45-70 kDa. Individual analysis of the venom pattern 
of the Hungarian adders revealed a few gender-specific differences and similarities. There 
was no difference in the venom complexity associated with the number of protein bands 
between females (n=14) and males (n=11): the average number of bands is 12 in males, while 
it is 11.9 in case of females. Four protein bands (61, 37, 30, and 21 kDa) were found in male 
venoms that were absent in female ones. On the other hand, there were three protein bands 
(83.5, 75, 57.5 kDa) found only in the female adder venoms. Some age-related differences 
could be also observed on the electrophoretic profile of venoms. Only the venom pattern of 
juveniles contained bands with molecular weights of 37, 41, 59, 61 and 79 kDa; these bands 
were completely absent in the venom pattern of subadult and adult snakes. Venom pattern of 
subadults and adults is characterized by bands of molecular weights 27, 34, 44, 66, and 85 
kDa that were not mirrored in the venom of juveniles. The dendrogram resulting from the 
UPGMA is showed in figure 1B. A cross line at the 0.82 dissimilarity level divided the 
dendrograms into three major groups: one contains the Austrian adder sample and the sample 
of V. nikolskii, while another contains the samples of juveniles, and a third group consists of 
the samples of subadult together with adult specimens. Our dendrogram had a cophenetic 
correlation of 0.93, suggesting that the dendrogram provides an excellent representation of the 
resemblances. 
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3.3. Analysis of the phospholipase A2 (PLA
2
) content of venoms by MALDI-TOF MS 
In order to assess the possible intra-population variations, the MALDI-TOF spectra of 
PLA2 content of all (n=25) the Hungarian adder venom samples and the two controls were 
compared. Unambiguous heterogeneity mirrored in the PLA2 content of individual venoms in 
the molecular mass range between 13500 and 14400 Da; the detected molecular masses of 
components by MALDI-TOF-MS is shown by table 1.  
The Hungarian venoms gave from 4 to 7 peaks - depends on the specimens - in the 
molecular weights that vary between 13548 and 14340 Da. Five or six peaks were recorded in 
72% of the samples. Of the Hungarian samples, the venom of females gave an average 5.1 
peaks, while males gave 5.4 peaks between 13500 and 14400 Da; the difference was 
statistically insignificant between the genders (P-value= 0.8815, at 95% confidence interval, 
2-tailed). The average number of peaks in the different age-groups was the following: 4.4 in 
juveniles, 5.6 in subadults and 5.3 in adults. The difference was not significant between the 
different age-groups (juveniles-subadults: P-value=0.6668; juveniles-adults: P-value=0.7386; 
and subadults-adults: P-value=0.8934, at 95% confidence interval, 2-tailed). All the 
Hungarian samples contain component in the mass range between 13571 and 13587 Da. A 
very characteristic mass peak, which was the most intensive one, was identified at the range 
of 13800 Da in 88% of the Hungarian adder venoms and only 16% of the Hungarian samples 
gave any peak in the molecular mass range of 13700 and 14200 Da. Representative spectra of 
venoms are shown in figure 2. Spectrogram of the control Austrian adder venom showed 5 
peaks between 13550.03 and 14283.20 Da (Fig. 2). The other control venom, sample of V. 
nikolskii could be characterized by the presence of 3 peaks only (Fig. 2). In the Austrian V. b. 
berus sample, the most intense peak was also detected in the range of 13800, while it was at 
13600 Da in case of V. nikolskii. Of the 5 molecular mass peaks in the Austrian V. b. berus 
venom, there were two components with the same molecular masses (13893.93 and 14094.04 
Da) that were also identified in the venoms of the Hungarian adders, although, these were 
present only in two specimens. The venom of V. nikolskii did not contain any components 
detected with the same molecular mass in the range of PLA2s as in the venoms of Hungarian 
snakes. 
 
3.4. Phospholipase A2 (PLA2) activity assay 
The total PLA2 activities of the individual venoms were also compared. Of the 
Hungarian specimens, the lowest activity was 385 kU/mg, while the highest was 619 kU/mg. 
Results are presented as mean ± SEM: i) juveniles:  515 kU/mg (±57), ii) subadults: 506 
kU/mg (±61), and iii) adults: 492 kU/mg (±54). The activity of individual samples differed 
from each other but no significant differences in population means were found in either 
groups (p=0.8582 for sex-group, and p=0.8241 for age-group), nor in group interaction 
(p=0.7773). The control samples showed 546 kU/mg (Austrian V. b. berus) and 431 kU/mg 
(V. nikolskii), respectively.  
 
3.5. Protease activity assay/substrate zymography 
Clear and significant individual venom variations were detected on the zymograms 
using gelatine substrate (figure 3). Gelatinolytic activity could be observed in bands around 
34-37, 45-50, and 60 kDa. Of 20 investigated venoms, certain samples (samples: 7; 11; 14; 
15; 17; Fig. 3.) showed intensive gelatine-degradations around 34.7 and 45 kDa on the 
substrate, while these were weakly observed between 45 and 70 kDa in case of some venoms 
(samples: 8; 9; 10; 18; 19; Fig. 3.). Degradations could hardly or not been detected in a few 
Hungarian samples (samples: 12; 13; 16; 23) shown in figure 3. On the bases of the gelatine-
zymogram, the control Austrian V. b. berus venom had much lower enzymatic activity than 
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that of the most Hungarian V. b. berus venoms. The venom of V. nikolskii was almost devoid 
of this type of activity demonstrated by our substrate zymography. 
 
3.6. Lethal toxicity (LD50) of crude venoms 
In case of all the tested Hungarian venom samples (n=4; their sex and age are shown 
by Fig. 4) envenoming resulted in characteristic signs on mice, i.e. head-drop and floppy 
neck, progressive respiratory paralysis preceded by initial increase in respiration rate and 
limb-paralysis prior to death from respiratory paralysis. Following administration of 0.80 µg/g 
i.v. to mice, these symptoms developed within circa 40 min, and death followed 1-1.5 h after 
venom injection. All of the above-mentioned characteristic paralytic signs of envenoming 
were also visible on mice after the injection of V. nikolskii venom. While these were lacked in 
case of the maximum dose (1.0 µg/g i.v.) of the Austrian V. b. berus sample, although, it was 
lethal in 100% in the given dose (after the injection of the Austrian venom, mice were able to 
move till the last moment, when the respiration had become irregular and very intensive 
directly prior to death). LD50 value of the most toxic sample was 0.41 µg/g i.v. (Fig. 4). The 
Log-ORJLVWLFGLVWULEXWLRQ ILWWHGEHVW IRURXUGDWD DV UHYHDOHGE\ WKH3HUVRQ¶VJRRGQHVV-of-fit 
WHVW 3HUVRQ Ȥ2  GI  S  'HYLDQFH Ȥ2=23.38, df=27, p=0.66). The regression 
slopes equality among the venoms was not violated (Test for eTXDOVORSHVȤ2=9.07731, df=5, 
p=0.106). The detected significant differences in LD50 values are presented on figure 4. 
 
3.7. Neuromuscular studies on chick biventer cervicis (CBC) nerve-muscle preparations 
In the first set of experiments, two Hungarian V. b. berus venom samples were 
randomly chosen and tested on isolated CBC nerve-muscle preparation (Fig 5). The Austrian 
V. b. berus venom was used as a control. All the three venom samples caused a slow 
progressive reduction in the height of the twitch response at 10 Pg/ml. There was some initial 
augmentation in preparations exposed to the Austrian V. b. berus. After 180 minutes in venom 
at 10 Pg/ml, twitch height was about 20% of control (pre-venom) height. Responses of the 
preparations to the exogenous agonists (acetylcholine, carbachol and KCl) were tested after 
complete twitch block. There was little change in preparations exposed to the two Hungarian 
venoms (sample 23 and 20), while responses to all three stimuli were reduced in preparations 
exposed to the Austrian (sample 26) venom. At higher concentration, the reduction in twitch 
responses to indirect stimulation was faster than with 10 Pg/ml and all preparations were 
completely blocked. Some preparations showed a small, slowly developing and slowly 
waning contracture during the onset of twitch block (not shown). Similar preparation 
responses were detected to the agonists after complete twitch block when the preparations 
were exposed to higher venom concentration, but responses to all the three stimuli were 
markedly reduced in preparation exposed to the Austrian venom sample at 30 µg/ml. There 
was no recovery after wash-out of the venoms in each case (not shown).  
In further experiments, more samples from the Hungarian venoms were randomly 
chosen and also tested on CBC nerve-muscle preparations (Fig 5). In this case, the control 
venom was V. nikolksii (sample 27). The venom concentration was 30 Pg/ml and the twitch 
height was measured after 30 minutes and then, an additional 70 Pg/ml was added (total 
venom concentration was 100 Pg/ml). The time to 50% block was recorded and after about 
120 minutes total exposure, responses to acetylcholine, carbachol and potassium chloride 
were determined. All samples apart from one (sample: 13) reduced the twitch responses to 
nerve stimulation. 
 
4. Discussion 
Snake venoms are highly complex biologically active mixtures but their composition 
can be influenced by several extrinsic and intrinsic factors. These can affect their biochemical 
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and pharmacological properties, resulting in intraspecific venom variations - between separate 
geographical populations and even within population that might have clinical implications 
(Ferquel et al., 2007; Casewell et al., 2014).  
Significant individual differences were detected in the dry-weight of milked venoms in 
different approximate age-groups of the adders. Compared to published data on V. berus 
venom yields, our results most closely resembled data from Brown (1973), suggesting an 
average yield of 6 mg.  
Our results show great individual variations, involving gender-specific and age-related 
differences in the venom protein profiles, demonstrated by non-reduced SDS-PAGE gel. 
Ontogenetic shift in diet is a plausible explanation for the differences in the venom 
composition between juvenile and adult adders. In many habitats, juveniles prefer lizards 
(genera Lacerta and Zootoca), whereas adults prefer small rodents (Nilson et al., 2005). 
However, venom composition at the individual level is influenced by genetic as well as 
environmental factors (Casewell et al., 2014). Perhaps dynamics of protein production and 
peptide maturation in juveniles differs from that in adults, contributing to variations in venom 
protein profiles.  
There was also marked individual variability in molecular masses of components as 
detected by MALDI-TOF MS, corresponding to previously published molecular ranges of 
PLA2s from the venoms of Vipera species (Jan et al., 2007). We suggest that the presence or 
absence of a given PLA2 in the venoms of different individual snakes can be the result of 
differences in gene encoding, determined by ecological factors, as well as control of gene 
expression and/or gene frequencies within the same adder population where our venom 
samples were collected. PLA2 spectra of Hungarian V. berus venoms resembled the Austrian 
V. berus control venom, but differed markedly from the V. nikolskii venom.  
Total PLA2 and protease activity were chosen to characterization individual venoms 
biochemically. However, significant individual differences in PLA2 activity were not 
observed, although variability was revealed in protease activity from different specimens. In 
this latter case, some specimens shared a conserved region of substrate degradation, while 
others were completely devoid of protease activity on the gelatine substrate. The degradation 
profile of venoms correlates with the detected YDULDELOLW\ LQ WKH YHQRPV¶ electrophoretic 
protein expression profile, associating with the serine- and metalloproteinases, mainly in the 
range of 45-70 kDa. However, the venom of this taxon contains these proteases (Samel et al., 
2003) that are primary responsible for causing oedema and bruising in envenomings by 
European Vipera (Persson, 2015). We suggest that the low or absent venom protease activity 
combined with the low average venom yield of the eastern Hungarian adders explains the 
mild local symptoms in patients bitten in this region (Malina et al., 2008, 2013). 
In general, the venom of V. b. berus is thought to be devoid of neurotoxic activity 
(.ULåDMHW DO5DPD]DQRYDHW DOGH+DURHWDO0DJGDODQHWDO). 
However, cranial nerve involvement in humans envenomed by V. b. berus, have been 
documented sporadically in the early literature and, more recently (Table 2). Without 
exception these incidents derive from the Carpathian Basin. Evidence of neurotoxic activity of 
V. b. berus venom, using the chick biventer cervicis nerve-muscle preparation, was found in 
all but one sample of venoms from adders living in the region of Hungary where neurotoxic 
envenomings have been reported (Malina et al., 2008, 2013).  The effects were consistent 
with block of ACh release of from the motor nerve terminals combined with minor effects on 
ACh receptors or directly on skeletal muscle in the Hungarian adder and V. nikolskii venom. 
The Austrian V. b. berus venom differed markedly from the Hungarian adder venoms and 
from V. nikolskii venom by reducing responses to all three postjunctional agonists, indicating 
a myotoxic effect. As far as snake taxonomy is concerned, these findings confirm that 
possession of venom neurotoxin by members of V. berus sub-species is not a reliable indicator 
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of taxonomic sub-divisions (Ramazanova et al., 2008). Among European viper species, 
prejunctional block tends to be associated with venom PLA2 content (Jan et al., 2007). 
However, all our studied samples, including the non-neurotoxic one, had many molecular 
species in the mass ranges of typical PLA2s, implying the presence of both toxic and non-
toxic PLA2s.  
The high lethal toxicity of the Hungarian adder venoms in mice could be attributable 
to their prejunctionally-acting PLA2s, since PLA2-dependent skeletal neuromuscular junction 
specific neurotoxins are the most toxic venom components, which rapidly kill the prey, 
predominant by immobilizing them. 
In summary, specimens of the investigated lowland V. b. berus population in a defined 
area in eastern Hungary have evolved variable venom phenotypes. Marked individual 
variability is reflected not only in their electrophoretic venom profile but also in the spectra of 
PLA2 content and certain enzymatic, pharmacological and biological activities. Our results 
illustrates that these adder venoms consist of a mixtures of multiple toxic components - 
including neurotoxins - which show remarkable individual variability combined with an 
average low venom yield. As a result, it is not surprising that envenomed humans 
occasionally manifest atypical clinical features. This intra-population venom variability 
contributes to the wider range of clinical manifestations of envenoming, including unusual 
clinical signs notably neurological features that are not typical of V. b. berus envenomings 
elsewhere in Europe.  
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Tables: 
 
Table 1. Data of snakes and the molecular mass peaks in the range of PLA2s (13000-15000 
Da) detected in their venoms by MALDI-TOF-MS. Underlined components are the common 
components present in the individual venoms. 
Legend: F=female; M=male; *= not recorded; A=adult (58.3-77.4 cm); Sa=Subadult (42.5-50.7 cm); J=Juvenile 
(16.2-36.7 cm) 
 
Specimen 
number 
on SDS-
PAGE gel 
Sex 
 
age-
group 
Total 
length 
in cm 
Mass peaks in Da 
 
1 F Sa 48.3 13571.78, 13680.64, 13889.81, 14098.17, 14200.50 
2 F A 70 13587.57, 13705.36, 13914.09, 14117.50, 14315.69 
3 M Sa 45 13558.84, 13677.66, 13886.53, 14098.00, 14307.13 
4 F A 66 13548.35, 13665.44, 13875.59, 13984.77, 14091.58, 14282.36 
5 M A 58.3 13555.81, 13679.11, 13878.40, 14085.41 
6 M Sa 43.3 13571.10, 13682.39, 13770.59, 13889.30, 13951.32, 13988.96, 
14107.32   
7 F J 28.1 13563.24, 13682.02, 13892.11, 14106.38 
8 M J 22 13556.07, 13672.19, 13875.66, 14100.02 
9 M J 16.2 13559.24, 13676.09, 13885.18, 13986.22, 14096.58 
10 F J 26.3 13565.25, 13687.35, 13893.93, 14101.97 
11 M A 60.1 13587.67, 13724.53, 13916.70, 14121.61, 14322.08 
12 M Sa 42.5 13678.27, 13700.65, 13909.08, 14022.63, 14121.96, 14340.17 
13 F A 61 13558.54, 13677.21, 13889.11, 13996.17, 14098.99 
14 F A 77.4 13555.52, 13672.64, 13880.36, 13941.70, 14096.62 
15 M Sa 43.8 13556.07, 13671.17, 13880.43, 13984.55, 14097.37, 14299.47 
16 F A 59.8 13557.77, 13674.76, 13887.55, 14102.12, 14305.42 
17 M Sa 50.7 13555.48, 13665.77, 13874.31, 13955.67, 13971.57, 14084.54, 
14291.53 
18 F Sa 44.9 13567.79, 13684.87, 13897.19, 14109.43, 14320.71 
19 F Sa 47.6 13555.49, 13673.5, 13886.89, 13993.27, 14102.59, 14304.03 
20 F A 73.8 13571.77, 13687.30, 13897.15, 14004.33, 14112.52, 14323.60 
21 F A 70.1 13554.91, 13680.77, 13892.89, 14004.91, 14104.44, 14311.49 
22 M J 36.7 13561.72, 13677.41, 13886.73, 14018.60, 14094.54 
23 M A 60.2 13549.18, 13665.87, 13877.13, 13987.37, 14093.40, 14302.66 
24 F Sa 48.1 13555.61, 13672.42, 13880.38, 14093.70 
25 F A 69.7 13562.91, 13679.42, 13891.32, 13998.02, 14105.52, 14310.11 
Austrian 
V. b. berus 
* A * 13550.03, 13678.21, 13893.63, 14094.04, 14283.2    
V. nikolskii * A * 13654.60, 13842.53, 14043.29  
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Table 2. Case reports about neurotoxic envenomings by V. b. berus in the Carpathian basin, 
published so far in the scientific and/or medical literature.  
Legend: F=female; M=male; *= Malina et al. (2008) re-PHQWLRQHG6]pOO¶Vdata, reported in 1878. **= Malina et 
al. (2008) noted 3HWUDVNy¶V data, recorded in 1899. ***=In this case, the taxon was erroneously recorded as 
Vipera berus bosniensis by the authors because only the nominate subspecies of the adder (V. b. berus) occurs in 
Romania (Ursenbacher et al., 2006).  
 
Author 
 
Year of 
incident 
Locality of incident age of 
patient  
sex of 
patient 
recorded cranial nerve 
disturbances 
Malina et al.  
(2008)* 
1878 western Transylvania  24 years M bilateral ptosis, 
blindness 
 
Malina et al. 
(2008)** 
 
1895 
 
western Transylvania  
 
43 years 
 
F 
 
ophthalmoplegia 
 
Blatt (1923) 
 
1922 
 
Transylvania 
 
40 years 
 
F 
accommodation trouble, 
ophthalmoplegia, 
bilateral 
ptosis 
 
Malina et al. 
(2008) 
 
2007 
 
 
eastern Hungary 
 
27 years 
 
M 
 
diplopia, 
ophthalmoplegia 
 
Gafencu et al. 
(2012) *** 
 
not 
mentioned 
 
south-western 
Romania 
 
14 years 
 
F 
 
blurred vision, bilateral 
ptosis, dysphagia 
 
Strugariu and 
Strugariu 
(2014) 
2003-2011 north-eastern 
Romania 
9 years F bilateral ptosis 
Malina et al. 
(2013) 
2012 eastern Hungary 12 years F bilateral but partial 
ptosis, gaze paresis, 
diplopia 
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Figure captions: 
 
Figure 1. (A) SDS-PAGE photograph of the complete venom pattern (under non-reduced 
conditions) of the adders used in this study and (B) the cluster analysis of the grouped 
electrophoretic results. 
Legend on A): M=marker; Samples from 1 to 25=Hungarian V. b. berus; 26=AusVbb=Austrian V. b. berus; 
27=Vnik=V. nikolskii; A DGXOWVSHFLPHQ6D VXEDGXOWVSHFLPHQ- MXYHQLOHƃ PDOHƂ IHPDOH 
Legend on B): $Ƃ DGXOWIHPDOHV$ƃ DGXOWPDOHV6Dƃ VXEDGXOWPDOHV6DƂ VXEDGXOWIHPDOHV-ƃ MXYHQLOH
PDOHV-Ƃ MXYHQLOHIHPDOHVAusVbb=Austrian V. b. berus specimen; Vnik=V. nikolskii specimen 
 
Figure 2. Representative spectra of the PLA2 content of individual venoms in case of the 
Hungarian V. b. berus specimens and the two control venoms by MALDI-TOF MS (dimers 
are not shown). Spectrum represents four experiments in each case. Samples from the same 
specimens are presented with the same number as in figure 1. 
Legend: Molecular mass (in Da) is given each peak for each component present. Y axis is the intensity and X 
the molecular masses. Samples from the same specimens are presented with the same number as in figure 2. 
6DPSOHV MXYHQLOHƃ MXYHQLOHƂ DGXOWƂ VXEDGXOWƃ VXEDGXOWƂ DGXOWƃ VXEDGXOW
Ƃ26=Austrian V. b. berus; 27=V. nikolskii 
 
Figure 3. Substrate zymography of the venoms from the eastern Hungarian adders and the 
two control venoms on gelatine substrate. Enzymatic activity of the samples is indicated by 
the clear degradations (plaques) on the gel. Molecular mass markers (in kDa) are indicated at 
the left of the gels. Samples from the same specimens are presented with the same number as 
in figure 1. 
Legend: M=marker. Arrows with the numbers correspond to the position of molecular mass markers (M). 
A=adult specimen; Sa=subadult specimen - MXYHQLOH ƃ PDOH Ƃ IHPDOH AusVbb=Austrian V. b. berus 
specimen; Vnik=V. nikolskii specimen. 
 
Figure 4. LD50 values of the Hungarian V. b. berus individual venoms and the two controls. 
(A): pairwise relative potency comparison and between the venom samples (*=significant 
difference, values in parenthesis are represented the 95% confidence limits). (B): LD50 values 
of the tested samples. Samples from the same specimens are presented with the same number 
as in figure 1.    
 
Figure 5. Neuromuscular effects of venoms on chick biventer cervicis nerve-muscle 
preparations. Samples from the same specimens are presented with the same number as in 
figure 1.  
Legend: (A) and (C): time and concentration dependent inhibition of indirectly-stimulated twitch contractions 
by venoms. (B), (D) and (E): contractile responses of preparations to the exogenous acetylcholine (ACh), 
carbachol (Car) and potassium chloride (KCl) after complete inhibition of the nerve-evoked twitches. (F): lasted 
time to 50% twitch block on preparations. Sample 26 (Aus Vbb) was available only in a smaller amount. 
A=adult; Sa=subadult; J=juvenile specimen; Aus Vbb=Austrian V. b. berus; Vnik=V. nikolskii 
 
